| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |